publication venue for
- A priori prediction of breast tumour response to chemotherapy using quantitative ultrasound imaging and artificial neural networks. 10:3910-3923. 2019
- Etoposide-induced DNA damage affects multiple cellular pathways in addition to DNA damage response. 9:24122-24139. 2018
- The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy. 9:20439-20450. 2018
- Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study. 9:19861-19873. 2018
- A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209. 9:8155-8164. 2018
- Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression. 8:103428-103436. 2017
- Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells. 8:95674-95691. 2017
- Melatonin suppresses fibrotic responses induced by cigarette smoke via downregulation of TGF-β1. 8:95692-95703. 2017
- BMI1 reduces ATR activation and signalling caused by hydroxyurea. 8:89707-89721. 2017
- Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer. 8:77181-77194. 2017
- A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196. 8:69651-69662. 2017
- A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196.. 8:69651-69662. 2017
- Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials. 8:57733-57754. 2017
- Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials.. 8:57733-57754. 2017
- E6AP promotes prostate cancer by reducing p27 expression. 8:42939-42948. 2017
- Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts. 8:32101-32116. 2017
- MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer. 8:29540-29557. 2017
- Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome. 8:28093-28100. 2017
- Upregulation of FAM84B during prostate cancer progression. 8:19218-19235. 2017
- Amplification of MUC1 in prostate cancer metastasis and CRPC development. 7:83115-83133. 2016
- Akt isoform specific effects in ovarian cancer progression. 7:74820-74833. 2016
- Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells. 7:72608-72621. 2016
- Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells. 7:70546-70558. 2016
- Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin. 7:56408-56421. 2016
- Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer. 7:53137-53152. 2016
- A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial. 7:49099-49106. 2016
- Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer. 7:47343-47365. 2016
- MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway. 7:28000-28012. 2016
- Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects. 7:20532-20548. 2016
- Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression. 7:5677-5689. 2016
- miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma. 7:4009-4023. 2016
- Epigenetic silencing of miR-145-5p contributes to brain metastasis. 6:35183-35201. 2015
- Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis. 6:35564-35578. 2015
- A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials. 6:31693-31701. 2015
- STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation. 6:27461-27477. 2015
- Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread. 6:24061-24074. 2015
- Neoplastic human embryonic stem cells as a model of radiation resistance of human cancer stem cells. 6:22258-22269. 2015
- Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion. 6:18134-18150. 2015
- Identification and evaluation of network modules for the prognosis of basal-like breast cancer. 6:17713-17724. 2015
- miR-181c associates with tumor relapse of high grade osteosarcoma. 6:13947-13961. 2015
- miR-181c associates with tumor relapse of high grade osteosarcoma. 6:13946-13961. 2015
- A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations. 6:12637-12653. 2015
- Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy. 6:7040-7052. 2015
- Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression. 6:5547-5566. 2015
- Revealed: The spy who regulates neuroblastoma stem cells. 5:11014-11016. 2014
- Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma. 5:7406-7419. 2014
- Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells. 5:4129-4143. 2014
- Alterations of immune response of non-small cell lung cancer with Azacytidine. 4:2067-2079. 2013
- Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1). 4:329-345. 2013
- ID4: a new player in the cancer arena. 1:48-58. 2010